Literature DB >> 3496351

Changing osteocalcin concentrations during pregnancy and lactation: implications for maternal mineral metabolism.

D E Cole, C M Gundberg, L J Stirk, S A Atkinson, D A Hanley, L M Ayer, L S Baldwin.   

Abstract

We measured serum osteocalcin concentrations in 82 pregnant and 21 nonpregnant women. Osteocalcin values declined in the second trimester, but returned to nonpregnant levels late in the third trimester. The mean serum osteocalcin concentration in 36 women during pregnancy (mean gestation, 26 weeks) of 2.8 ng/mL was significantly lower than that in nonpregnant women (6.4 ng/mL; P less than 0.001) or term pregnant women at delivery (6.1 ng/mL; n = 46). Serum immunoreactive PTH (iPTH) levels were significantly higher during pregnancy than in nonpregnant women [97 +/- 5 vs. 56 +/- 4 ng/L (mean +/- SE); P less than 0.001]. No significant correlations were found between maternal osteocalcin concentrations and serum phosphorus, alkaline phosphatase, or iPTH, but significant negative correlations were found between osteocalcin and total calcium or total protein. Osteocalcin concentrations in midtrimester amniotic fluid were very low (mean, 0.3 +/- 0.1 ng/mL; n = 11). In 29 lactating mothers, the mean serum osteocalcin level was 9.5 +/- 1.5 ng/mL, significantly higher than in any of the other groups (P less than 0.05), but their serum calcium and iPTH levels were normal. There was no correlation between serum osteocalcin and calcium or iPTH concentrations in lactating women. These changes are compatible with a sequence in which bone turnover is reduced during early pregnancy, rebounds in the third trimester, and increases in postpartum lactating women.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496351     DOI: 10.1210/jcem-65-2-290

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

Review 2.  Osteoporosis in pregnancy.

Authors:  W Khovidhunkit; S Epstein
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease).

Authors:  N Chosich; F Long; R Wong; D J Topliss; J R Stockigt
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

4.  Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women.

Authors:  R Saucedo; G Rico; G Vega; L Basurto; L Cordova; R Galvan; M Hernandez; E Puello; A Zarate
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

5.  Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.

Authors:  O M Lepage; M Marcoux; A Tremblay
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

6.  Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia.

Authors:  Danijela Radojkovic; Milica Pesic; Milan Radojkovic; Dragan Dimic; Marija Vukelic Nikolic; Tatjana Jevtovic Stoimenov; Sasa Radenkovic; Milena Velojic Golubovic; Tatjana Radjenovic Petkovic; Slobodan Antic
Journal:  Endocrine       Date:  2018-08-24       Impact factor: 3.633

7.  Circadian rhythms of osteocalcin in equine serum. Correlation with alkaline phosphatase, calcium, phosphate and total protein levels.

Authors:  O M Lepage; L DesCôteaux; M Marcoux; A Tremblay
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

8.  Undercarboxylated osteocalcin is associated with insulin resistance, but not adiponectin, during pregnancy.

Authors:  Panudda Srichomkwun; Natnicha Houngngam; Sophitsachi Pasatrat; Thipaporn Tharavanij; Lalita Wattanachanya; Weerapan Khovidhunkit
Journal:  Endocrine       Date:  2015-12-26       Impact factor: 3.633

9.  Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation.

Authors:  C E Webber; D R Chettle; R J Bowins; L F Beaumont; C L Gordon; X Song; J M Blake; R H McNutt
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

10.  Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus.

Authors:  Yvonne Winhofer; Ammon Handisurya; Andrea Tura; Christina Bittighofer; Katharina Klein; Barbara Schneider; Christian Bieglmayer; Oswald F Wagner; Giovanni Pacini; Anton Luger; Alexandra Kautzky-Willer
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.